Abstract
Simple antibodies or vector-induced T cell immunity are unable to provide broad immunity to HIV. Although broadly reactive neutralising antibodies are a goal of vaccination, this remains elusive. There is growing evidence that HIV-specific antibodies that mediate their activity via the Fc-receptor, such as antibody dependent cellular cytotoxicity (ADCC), have an important role in controlling HIV infection. Newer assays are being developed that enable HIV-specific ADCC responses to be finely mapped. In turn, this should allow a more definitive analysis of the effectiveness of HIVspecific ADCC antibodies. However, progressive dysfunction of effector cells that mediate ADCC responses, such as NK cells, combined with immune escape variants that emerge from effective ADCC responses, likely undermine the utility of ADCC responses during chronic HIV infection. Nonetheless the utility of ADCC responses in preventing HIV infection requires urgent consideration.
Keywords: HIV, antibodies, ADCC, vaccine
Current HIV Research
Title: The Utility of ADCC Responses in HIV Infection
Volume: 6 Issue: 6
Author(s): Amy Chung, Erik Rollman, Susanne Johansson, Stephen J. Kent and Ivan Stratov
Affiliation:
Keywords: HIV, antibodies, ADCC, vaccine
Abstract: Simple antibodies or vector-induced T cell immunity are unable to provide broad immunity to HIV. Although broadly reactive neutralising antibodies are a goal of vaccination, this remains elusive. There is growing evidence that HIV-specific antibodies that mediate their activity via the Fc-receptor, such as antibody dependent cellular cytotoxicity (ADCC), have an important role in controlling HIV infection. Newer assays are being developed that enable HIV-specific ADCC responses to be finely mapped. In turn, this should allow a more definitive analysis of the effectiveness of HIVspecific ADCC antibodies. However, progressive dysfunction of effector cells that mediate ADCC responses, such as NK cells, combined with immune escape variants that emerge from effective ADCC responses, likely undermine the utility of ADCC responses during chronic HIV infection. Nonetheless the utility of ADCC responses in preventing HIV infection requires urgent consideration.
Export Options
About this article
Cite this article as:
Chung Amy, Rollman Erik, Johansson Susanne, Kent J. Stephen and Stratov Ivan, The Utility of ADCC Responses in HIV Infection, Current HIV Research 2008; 6 (6) . https://dx.doi.org/10.2174/157016208786501472
DOI https://dx.doi.org/10.2174/157016208786501472 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease
Current Aging Science Achieving Detumescence of Ischemic Priapism with Intra-Cavernosal Injection of entanyl: An Unexpected Outcome of Miscommunication Error
Current Drug Safety Targeting of Phage Display Vectors to Mammalian Cells
Combinatorial Chemistry & High Throughput Screening Molecule of the Month
Current Topics in Medicinal Chemistry Development and Validation of a UPLC–MS/MS Method for the Simultaneous Determination of Telmisartan and Metformine HCl in Human Plasma
Current Analytical Chemistry The Biochemical Mechanisms of T-Cell Anergy
Current Immunology Reviews (Discontinued) Editorial from Editorial Board Member [ Thoughts on Impact Factors and Editing of Medical Journals ]
Inflammation & Allergy - Drug Targets (Discontinued) Editorial (Thematic Issue: Natural Products for the Attenuation of Allergic Airway Inflammation)
Current Pharmaceutical Design Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
Current Medicinal Chemistry Anemia in Chronic Heart Failure - Clinical and Prognostic Significance
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Fibrosis in the Anterior Segments of the Eye
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammatory Biomarkers in Chronic Kidney Disease: A Review
Recent Patents on Biomarkers A Proteomics Perspective: From Animal Welfare to Food Safety
Current Protein & Peptide Science Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale
Current Pharmaceutical Design Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Editorial [ Hot Topic: Therapeutic Potential of Peptide Motifs - Part III (Executive Editor: Jean-Claude Herve) ]
Current Pharmaceutical Design From Biomarkers to Cytokine-like Hormones: Uncovering New Directives for Cognitive Loss and Alzheimer’s Disease
Current Neurovascular Research Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
Current Pharmaceutical Design Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets Pharmaceutical Drug Nanocrystals: Role in Dermal Delivery
Nanoscience & Nanotechnology-Asia